Skip to menu Skip to content Skip to footer

Nuclear medicine for the future: Targeted radiometal therapeutics for oncology (2021-2022)

Experts

Professor Kristofer Thurecht

Senior Group Leader and Deputy Director, Research (AIBN/CAI)
Australian Institute for Bioengineering and Nanotechnology
Kristofer Thurecht